Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors

by Andrea M. Chambers, Sandro Matosevic, Sandro Matosevic
Published 2019-07-01

Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies

by Sandro Matosevic
Published 2018-01-01

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells

by Andrea M. Chambers, Kyle B. Lupo, Sandro Matosevic, Sandro Matosevic
Published 2018-11-01

1177 Multifunctional natural killer cell engager releasing CXCL10 augments natural killer cell recruitment and anti-tumor efficacy against glioblastoma

by Sandro Matosevic, Xue Yao
Published 2023-11-01

1206 Immunometabolic modulation of engineered iPSC-NK cells for immunotherapy of solid tumors

by Sandro Matosevic, Shambhavi Borde
Published 2023-11-01

998 Identification of the role of oncometabolites on natural killer cell in the tumor microenvironment by CRISPR screening

by Xinyu Wu, Sandro Matosevic
Published 2023-11-01

<i>NT5E</i>/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma

by Jiao Wang, Sandro Matosevic
Published 2019-09-01

150 Targeted delivery of a PD-L1-blocking scFv by CAR-NK cells shows potential as a new approach to immunotherapy for glioblastoma

by Jiao Wang, Sandro Matosevic
Published 2021-11-01

1082 Enhancing NK cell-mediated anti-tumor activity through modulation of TIM-3

by Yuning Liu, Sandro Matosevic
Published 2023-11-01

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy

by Xinyu Wu, Sandro Matosevic
Published 2022-12-01

171 Targeting the Immunomodulatory roles of T-cell immunoglobulin– and mucin domain–containing (TIM)–3 on natural killer cells in glioblastoma

by Sandro Matosevic, Tram Dao
Published 2021-11-01

163 Nice: neoantigen-cytokine-chemokine multifunctional engager for NK cell immunotherapy of solid tumors

by Sandro Matosevic, Xue Yao
Published 2020-11-01

799 Neoantigen-cytokine-chemokine multifunctional natural killer cell engager for immunotherapy of solid tumors

by Sandro Matosevic, Xue Yao
Published 2021-11-01

CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma

by Kyle B. Lupo, Sandro Matosevic
Published 2020-06-01

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy

by Kyle B. Lupo, Sandro Matosevic
Published 2019-06-01

Adenosinergic Signaling Alters Natural Killer Cell Functional Responses

by Andrea M. Chambers, Jiao Wang, Kyle B. Lupo, Hao Yu, Nadia M. Atallah Lanman, Sandro Matosevic, Sandro Matosevic
Published 2018-10-01

Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

by Jiao Wang, Kyle B. Lupo, Andrea M. Chambers, Sandro Matosevic
Published 2018-12-01

TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation

by Tram N. Dao, Sagar Utturkar, Nadia Atallah Lanman, Sandro Matosevic
Published 2020-08-01

Immunotherapy in Lung Cancer: Current Landscape and Future Directions

by Hirva Mamdani, Sandro Matosevic, Ahmed Bilal Khalid, Gregory Durm, Shadia I. Jalal
Published 2022-02-01

Nanoparticle‐Mediated Intracellular Protection of Natural Killer Cells Avoids Cryoinjury and Retains Potent Antitumor Functions

by Xue Yao, Joshua J. Jovevski, Michaela F. Todd, Rui Xu, Yining Li, Jiao Wang, Sandro Matosevic
Published 2020-05-01